The Chandigarh-based Venus Remedies’ manufacturing facilities at Baddi Campus has secured Good Manufacturing Practices certificate from the Ministry of Health and Medical Education of Iran which will enable the Company to export its products to Iranian market.
Technical analysts believe that this is a major breakthrough for the Company as Iran holds a significant share in Middle Eastern Pharmaceutical market and would open door to other Middle Eastern Markets as well.
Syngene International, a unit of Indian biotechnology major BIOCON Group, has informed that it will offer fully integrated drug discovery services by partnering with Sapient Discovery, a US based Biotechnology Company.
Sapient Discovery uses integrated, proprietary computational and experimental laboratory technologies, and cellular biology and proprietary data mining to accelerate the drug discovery and optimization processes.
LIC Housing Finance (LICHFL) is planning to launch its new financial arm in the current quarter. The decision is aimed to strengthen its distribution network across the country. The company would start its new financial arm, headquartered at Bombay and expand its network across country at later stage.
The Director and Chief Executive of LICHFL, R R Nair said, "We are launching our financial services subsidiary called LIC Housing Finance Financial Services which will help us improve our disbursement of loans and other financial products, during the quarter."
Lalit Khaitan family owned Radico Khaitan Ltd is planning to sell about 26 per cent stake to global drink giants according to reports of financial newspaper The Economic Times. Bacardi and Pernod Ricard have shown interest to buy stakes in Radico as per banking and industry sources.
Radico Khaitan is the second largest spirits company in the country and known for its liquor brands 8PM Whiskey and Magic Moments Vodka. Promoters hold 48.7 per cent stakes in Radico Khaitan Ltd.
An open offer was made by Daiichi Sankyo to Zenotech Laboratories' shareholders at Rs 113.62 per share. This comes after it revised its earlier open offer price of Rs 160 per share.
Jayaram Chigrupati, MD, Zenotech Laboratories reacted to the development, "The agreement on open offer price was reached in July 2008. The agreed price was reached after shareholders filed a case post the Ranbaxy-Daiichi deal. The suit was withdrawn after Daiichi agreed to open offer price of Rs 160 per share."
Refex Energy, the part of BSE-listed Refex refrigerants, has informed that the firm is setting up a 50 MW solar PV power plant in Gujarat.
The Chandigarh-based Venus Remedies’ manufacturing facilities at Baddi Campus has secured Good Manufacturing Practices certificate from the Ministry of Health and Medical Education of Iran which will enable the Company to export its products to Iranian market. 
Syngene International, a unit of Indian biotechnology major BIOCON Group, has informed that it will offer fully integrated drug discovery services by partnering with Sapient Discovery, a US based Biotechnology Company. 
LIC Housing Finance (LICHFL) is planning to launch its new financial arm in the current quarter. The decision is aimed to strengthen its distribution network across the country. The company would start its new financial arm, headquartered at Bombay and expand its network across country at later stage.
Lalit Khaitan family owned Radico Khaitan Ltd is planning to sell about 26 per cent stake to global drink giants according to reports of financial newspaper The Economic Times. Bacardi and Pernod Ricard have shown interest to buy stakes in Radico as per banking and industry sources. 
An open offer was made by Daiichi Sankyo to Zenotech Laboratories' shareholders at Rs 113.62 per share. This comes after it revised its earlier open offer price of Rs 160 per share.
